HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pretargeted immunoscintigraphy: effect of hapten valency on murine tumor uptake.

Abstract
A method of radioimmunoscintigraphy using bivalent "Janus" haptens with an apparent enhanced affinity ("avidity") for the antibody is described. Janus with 50 micrograms pretargeted Mab WC3A11 resulted in significantly higher murine tumor concentrations (approximately 7%/g) compared to monovalent haptens (approximately 1.4%/g, p < 0.001), and the same high tumor-to-background ratios (approximately 3/1). Janus was synthesized by coupling two molecules of BABE together with a 1,4 butanedithiol linker. Janus itself was rapidly excreted (T1/2b = 42 min) by the kidneys and did not concentrate in any other organs or tissues. Three-step pretargeted immunoscintigraphy (binder, chaser, tracer) with 111In- or 67Ga-Co(III) Janus produced excellent mouse tumor images in 3 hr with high tumor-to-background ratios. The use of short-lived tracers, such as 99mTc and 68Ga, with a T1/2p of hours to image antibodies that localize slowly over several days in vivo is accessible with this new technology.
AuthorsD A Goodwin, C F Meares, M McTigue, W Chaovapong, C I Diamanti, C H Ransone, M J McCall
JournalJournal of nuclear medicine : official publication, Society of Nuclear Medicine (J Nucl Med) Vol. 33 Issue 11 Pg. 2006-13 (Nov 1992) ISSN: 0161-5505 [Print] United States
PMID1432163 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Monoclonal
  • Gallium Radioisotopes
  • Haptens
  • Indium Radioisotopes
Topics
  • Animals
  • Antibodies, Monoclonal (immunology)
  • Antibody Affinity
  • Gallium Radioisotopes
  • Half-Life
  • Haptens (immunology)
  • In Vitro Techniques
  • Indium Radioisotopes
  • Mice
  • Mice, Inbred BALB C
  • Neoplasms, Experimental (diagnostic imaging)
  • Radioimmunodetection (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: